Latest Regulatory News

Hastings Technology Metals has responded to an ASX price query, denying any undisclosed information behind its recent share price and volume spike, citing recent joint venture and asset sale announcements as likely drivers.

Johns Lyng Group shareholders have overwhelmingly approved a scheme of arrangement for acquisition by Pacific Equity Partners, pending final court approval.

NH3 Clean Energy updates investors on the WAH2 clean ammonia project, highlighting strong market potential, strategic partnerships, and robust project economics as it moves toward a Final Investment Decision.

PainChek Limited has achieved a landmark FDA De Novo classification for its PainChek Adult App, positioning it as the first regulated medical device for pain assessment in the US aged care sector and opening a $100 million annual market opportunity.

Anatara Lifesciences has completed the first tranche of its two-part share placement, issuing over 33 million ordinary shares to professional investors. This move marks a significant step in the company’s capital raising efforts amid ongoing product development.

Power Minerals Limited has secured an option to acquire the Gamma Heavy Rare Earths Project in California, adjacent to the Mountain Pass Mine, backed by a $4.1 million placement to accelerate exploration.

Kula Gold Limited has addressed recent share price and volume spikes, confirming no undisclosed information while highlighting exploration progress and market factors driving investor interest.

Winsome Resources has resolved a regulatory hurdle to receive 17.65 million shares in Power Metals Corp, increasing its stake to 16.15% and reinforcing its position in critical minerals. Combined with a strong cash balance, this move strengthens Winsome’s liquidity and strategic outlook.

Neurotech International has secured a key FDA designation for its lead drug NTI164, advancing its potential to treat Rett syndrome with regulatory and financial benefits.

Greenwing Resources has unveiled a scoping study for its Que River polymetallic project in Tasmania, outlining a low capital expenditure route to potentially generate A$63 million in cash flow within a year. The study leverages existing infrastructure and highlights significant exploration upside beneath existing pits.

Alligator Energy has begun construction of its Samphire Project Field Recovery Trial near Whyalla, marking a key step towards uranium production amid a strengthening market.

Adamantem Capital Management has completed its due diligence on Apiam Animal Health and extended its exclusivity period to negotiate a potential $0.87 per share acquisition. The deal remains subject to approvals and binding agreements.